131 related articles for article (PubMed ID: 19458537)
1. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension.
Zhang Y; Wu JH; Vickers JJ; Ong SL; Temple SE; Mori TA; Croft KD; Whitworth JA
J Hypertens; 2009 Aug; 27(8):1609-16. PubMed ID: 19458537
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid metabolism in glucocorticoid-induced hypertension.
Zhang Y; Hu L; Mori TA; Barden A; Croft KD; Whitworth JA
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):557-62. PubMed ID: 18067589
[TBL] [Abstract][Full Text] [Related]
3. Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension.
Thida M; Earl J; Zhao Y; Wang H; Tse CS; Vickers JJ; Sutton M; Ong SL; Mori TA; Croft KD; Whitworth JA; Zhang Y
Am J Hypertens; 2010 May; 23(5):569-74. PubMed ID: 20186125
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats.
Hoagland KM; Flasch AK; Roman RJ
Hypertension; 2003 Oct; 42(4):669-73. PubMed ID: 12874093
[TBL] [Abstract][Full Text] [Related]
5. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
[TBL] [Abstract][Full Text] [Related]
6. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
Zhang Y; Croft KD; Mori TA; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
[TBL] [Abstract][Full Text] [Related]
7. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat.
Zhang Y; Jang R; Mori TA; Croft KD; Schyvens CG; McKenzie KU; Whitworth JA
J Hypertens; 2003 Aug; 21(8):1513-8. PubMed ID: 12872045
[TBL] [Abstract][Full Text] [Related]
8. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat.
Miao Y; Zhang Y; Lim PS; Kanjanapan Y; Mori TA; Croft KD; Earl J; Lee SY; McKenzie KU; Hu L; Whitworth JA
Am J Hypertens; 2007 Mar; 20(3):304-10. PubMed ID: 17324744
[TBL] [Abstract][Full Text] [Related]
9. Aspirin prevents and partially reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Miao Y; Whitworth JA
Am J Hypertens; 2007 Nov; 20(11):1222-8. PubMed ID: 17954371
[TBL] [Abstract][Full Text] [Related]
10. Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.
Mu Y; Klamerus MM; Miller TM; Rohan LC; Graham SH; Poloyac SM
Drug Metab Dispos; 2008 Nov; 36(11):2324-30. PubMed ID: 18725506
[TBL] [Abstract][Full Text] [Related]
11. The effect of alpha-lipoic acid on mitochondrial superoxide and glucocorticoid-induced hypertension.
Ong SL; Vohra H; Zhang Y; Sutton M; Whitworth JA
Oxid Med Cell Longev; 2013; 2013():517045. PubMed ID: 23533693
[TBL] [Abstract][Full Text] [Related]
12. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats.
Toth P; Csiszar A; Sosnowska D; Tucsek Z; Cseplo P; Springo Z; Tarantini S; Sonntag WE; Ungvari Z; Koller A
Br J Pharmacol; 2013 Apr; 168(8):1878-88. PubMed ID: 23194285
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.
Fernandez MM; Gonzalez D; Williams JM; Roman RJ; Nowicki S
Eur J Pharmacol; 2012 Jul; 686(1-3):97-103. PubMed ID: 22575524
[TBL] [Abstract][Full Text] [Related]
15. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.
Miyata N; Taniguchi K; Seki T; Ishimoto T; Sato-Watanabe M; Yasuda Y; Doi M; Kametani S; Tomishima Y; Ueki T; Sato M; Kameo K
Br J Pharmacol; 2001 Jun; 133(3):325-9. PubMed ID: 11375247
[TBL] [Abstract][Full Text] [Related]
16. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.
Hoagland KM; Maier KG; Roman RJ
Hypertension; 2003 Mar; 41(3 Pt 2):697-702. PubMed ID: 12623982
[TBL] [Abstract][Full Text] [Related]
17. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Dunn KM; Renic M; Flasch AK; Harder DR; Falck J; Roman RJ
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2455-65. PubMed ID: 18952718
[TBL] [Abstract][Full Text] [Related]
18. Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.
Williams JM; Sarkis A; Lopez B; Ryan RP; Flasch AK; Roman RJ
Hypertension; 2007 Mar; 49(3):687-94. PubMed ID: 17210834
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
Seki T; Wang MH; Miyata N; Laniado-Schwartzman M
Biol Pharm Bull; 2005 Sep; 28(9):1651-4. PubMed ID: 16141533
[TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
Mišir M; Renić M; Novak S; Mihalj M; Ćosić A; Vesel M; Drenjančević I
Exp Physiol; 2017 Dec; 102(12):1596-1606. PubMed ID: 28940693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
